Acuta Capital Partners LLC Makes New $1.29 Million Investment in NewAmsterdam Pharma (NASDAQ:NAMS)
MarketBeat
Acuta Capital Partners LLC acquired a new stake in shares of NewAmsterdam Pharma (NASDAQ:NAMS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 50,000 shares of the company's stock, valued at approximately $1,285,000. NewAm
NASDAQ:NAMS